Evaluation of the Global Auditory Nerve Activity for Exploration of Hearing in Humans
NCT ID: NCT03552224
Last Updated: 2021-12-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2018-07-11
2021-06-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Subjects with no hearing loss
Subjects referred for cerebellopontine angle surgery with no hearing loss with recording of auditory nerve activity by contact electrode
Recording of auditory nerve activity
near field recording of auditory nerve activity with contact electrode
Subjects with hearing loss
Subjects referred for cerebellopontine angle surgery with hearing loss with recording of auditory nerve activity by contact electrode
Recording of auditory nerve activity
near field recording of auditory nerve activity with contact electrode
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Recording of auditory nerve activity
near field recording of auditory nerve activity with contact electrode
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patient having to undergo surgery at the level of the ponto-cerebellar angle (microvascular decompression, vestibular neurotomy, tumor resection of the meningioma type or schwannoma) and
* Unaffected by neuro-sensory hearing loss, defined by mean auditory thresholds of less than 20 dB in tone audiometry in bone conduction on the side of the ear to be operated (N = 15, Group 1) or
* Showing mild to moderate hearing loss defined by average hearing loss (average of 500, 1000, 2000 and 4000 Hz thresholds) greater than 20 dB and less than 55 dB in air conduction threshold tone audiometry (N = 15 Group 2).
* Voluntary subjects to participate in the study,
* Subjects having signed written consent to participate in the study,
* Easily accessible topics.
Exclusion Criteria
* Subjects refusing to participate, subjects whose free and informed consent has not been sought, subjects for which a consent form has not been signed,
* Subjects for whom there is a contraindication to general anesthesia,
* Subjects with a central neurological pathology that can disrupt electrophysiological recordings
* Not affiliated to a French social security scheme or not benefiting from such a scheme,
* Majors protected by law,
* Pregnant women,
* deprived of liberty by judicial or administrative decision,
* Infectious or inflammatory pathology of the middle ear.
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institute for Neurosciences of Montpellier U1051
UNKNOWN
Reims University hospital
OTHER
University Hospital, Montpellier
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Frédéric VENAIL, PU-PH
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Montpellier
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Montpellier
Montpellier, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
9890
Identifier Type: -
Identifier Source: org_study_id